$CLFD

Beranek Cheryl sold $125K of CLFD

Beranek Cheryl (Chief Executive Officer) sold 2,500 shares of Clearfield, Inc. (CLFD) at $50.00 ($0.12M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Beranek Cheryl
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLFD
Neutral
high confidence
Mentioned
$CLFD
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLFDNeutralLow
01

Why it matters

The newest fact is the CEO’s disclosed sale size, price ($50.00/share), and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around CLFD due to insider selling, but the 10b5-1 framing makes it more informational than directional.

03

What to watch

The article does not state whether other insiders sold/bought, whether the CEO’s total position changed materially, or whether there were concurrent corporate events.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-05-28 for a sale dated 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Clearfield, Inc.

Company-level read

Ticker impact

$CLFDNeutralHigh confidence
Context

Clearfield CEO Beranek Cheryl sold 2,500 shares for $125,000 under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment effects.

Evidence & confidence

The filing specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with valuation or liquidity needs, so traders may still watch for follow-on selling or other disclosures.

Key entities

  • Clearfield, Inc.

    Company whose CEO insider sale is disclosed in the Form 4.

  • Beranek Cheryl

    Chief Executive Officer and director who sold shares.

Related articles

$CLFDMedAI 8/10

Clearfield Q3 Earnings Call Highlights

Clearfield (NASDAQ:CLFD) reported Q3 gross margin of 31.8% versus 35.3% a year earlier, with one-time items reducing margin by about 1.8 points, and operating expenses down 6% to $11.4M. Management cited constrained broadband demand and BEAD delays, plus limited fiber supply, and lowered FY2026 guidance to $151M-$155M net sales and $0.14-$0.21 diluted EPS. CLFD repurchased ~31,000 shares for $897k.

$CLFDMedAI 8/10

Clearfield: Fiscal Q3 Earnings Snapshot

Clearfield Inc. (CLFD) reported fiscal Q3 earnings of $3 million, or 22 cents per share, on revenue of $43.9 million. For the quarter ending in September, the company expects revenue of $38 million to $42 million. For the full year, it forecasts earnings of 14 to 21 cents per share and revenue of $151 million to $155 million.